Petlife Pharmaceuticals PTLF Stock
Petlife Pharmaceuticals Price Chart
Petlife Pharmaceuticals PTLF Financial and Trading Overview
| Petlife Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0003 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0003 - 0.0003 USD |
| 52 Week Range | 0.0001 - 0.003 USD |
| Volume | 946 USD |
| Avg. Volume | 18.2K USD |
| Market Cap | 393.5K USD |
| Beta (5Y Monthly) | 0.290492 |
| PE Ratio (TTM) | 0.0075000003 |
| EPS (TTM) | 0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PTLF Valuation Measures
| Enterprise Value | 856.07K USD |
| Trailing P/E | 0.0075000003 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Petlife Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.290492 |
| 52-Week Change | 200.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.003 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000488 USD |
| 200-Day Moving Average | 0.0009425 USD |
PTLF Share Statistics
| Avg. Volume (3 month) | 18.2K USD |
| Avg. Daily Volume (10-Days) | 94 USD |
| Shares Outstanding | 196.75M |
| Float | 72.27M |
| Short Ratio | N/A |
| % Held by Insiders | 6.42% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2017 |
| Most Recent Quarter (mrq) | February 28, 2018 |
| Next Fiscal Year End | August 31, 2018 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -1362.17% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -17915 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3708159 USD |
| Diluted EPS (ttm) | 0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.86K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 801.65K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.004 |
| Book Value Per Share (mrq) | -0.025 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -261905 USD |
| Levered Free Cash Flow (ttm) | 734.37K USD |
Profile of Petlife Pharmaceuticals
| Country | United States |
| State | CA |
| City | Los Angeles |
| Address | 8033 Sunset Boulevard |
| ZIP | 90046 |
| Phone | 424-216-6807 |
| Website | N/A |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.
Q&A For Petlife Pharmaceuticals Stock
What is a current PTLF stock price?
Petlife Pharmaceuticals PTLF stock price today per share is 0.0001 USD.
How to purchase Petlife Pharmaceuticals stock?
You can buy PTLF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Petlife Pharmaceuticals?
The stock symbol or ticker of Petlife Pharmaceuticals is PTLF.
Which industry does the Petlife Pharmaceuticals company belong to?
The Petlife Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Petlife Pharmaceuticals have in circulation?
The max supply of Petlife Pharmaceuticals shares is 3.94B.
What is Petlife Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Petlife Pharmaceuticals PE Ratio is 0.01000000 now.
What was Petlife Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Petlife Pharmaceuticals EPS is 0.01 USD over the trailing 12 months.
Which sector does the Petlife Pharmaceuticals company belong to?
The Petlife Pharmaceuticals sector is Healthcare.